Sort
15,842 grants matching “pancreatic cancer”
The Oral Mycobiome and Risk of Pancreatic Cancer
$646,256Jiyoung Ahn · New York University School Of Medicine · U01 · FY2021 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$646,146Robert H Vonderheide · University Of Pennsylvania · P01 · FY2021 · CA
Bacterial biosensors for the prevention of gastrointestinal cancers
$645,698Jeff M Hasty · University Of California, San Diego · R01 · FY2024 · CA
Flexible Tools for Pre-Clinical Studies to Answer Key Questions UnderlyingHeavy-Ion Radiotherapy
$645,692David Jonathan Brenner · Columbia University Health Sciences · U01 · FY2021 · CA
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
$645,670Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
$645,565Vadim Backman · Northwestern University · R01 · FY2016 · CA
Discovery of Novel Inhibitors Targeting trans-Golgi Network Acidification in Pancreatic Cancer
$645,331Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$645,116Sanku Mallik · North Dakota State University · P20 · FY2022 · GM
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$644,986Robert H Vonderheide · University Of Pennsylvania · R01 · FY2022 · CA
Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer
$644,927Paras N. Prasad · State University Of New York At Buffalo · R01 · FY2008 · CA
Clinical Trials with Immunotoxins
$644,817Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
$644,467Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$644,409Phil Crews · University Of California Santa Cruz · R01 · FY2015 · CA
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
$644,076Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2016 · CA
Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers
$643,951Brian B Haab · Van Andel Research Institute · U01 · FY2022 · CA
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$643,945Sanku Mallik · North Dakota State University · P20 · FY2019 · GM
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$643,945Sanku Mallik · North Dakota State University · P20 · FY2017 · GM
Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer
$643,395Paras N. Prasad · State University Of New York At Buffalo · R01 · FY2007 · CA
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications
$643,387Michael John Evans · University Of California, San Francisco · R01 · FY2022 · EB
Multifunctional Biodegradable Zwitterionic Polymer-Drug Conjugates for Multidrug Co-Delivery
$643,152Chong Cheng · State University Of New York At Buffalo · R01 · FY2023 · EB
Patient-specific, high-sensitivity spectral CT for assessment of pancreatic cancer
$643,028Peter B Noãl · University Of Pennsylvania · R01 · FY2021 · EB
T Cell Alternative p38 Activation Pathway
$642,994Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Design and characterization of bacterial population dynamics in solid tumor models
$642,937Jeff M Hasty · University Of California, San Diego · R01 · FY2021 · EB
Integrating Epigenetic Modulation into DNA Damage Repair
$642,872Pamela N Munster · University Of California, San Francisco · R01 · FY2023 · CA
HIFU-immunotherapy in pancreatic cancer
$642,831Katherine W Ferrara · Stanford University · R01 · FY2021 · CA